CDA and cancer: However, treatment with 5-Aza-2′-Deoxycytidine (5-Aza-dC), a DNA methyltransferase activity inhibitor, significantly increases CDA expression in cancer cell lines derived from breast, lung ovarian and melanoma tumors with a low initial CDA expression level.